Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes

Cell and Bioscience

Volumn 4, Issue 1, 2014, Pages

  Liu, Mandy ^a   Ravula, Ranadheer ^a   Wang, Zhijun ^a   Zuo, Zhong ^b   Chow, Moses S S ^a   Thakkar, Arvind ^a   Prabhu, Sunil ^a   Andresen, Bradley ^a   Huang, Ying ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Breast cancer; Cancer chemoprevention; HMOX1; Nrf2; ROS; Si Wu Tang; SLC7A11; Z liguistilide

Indexed keywords

EID: 84893641127     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-4-8     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Ilic D, Misso M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas 2012, 72:269-276. 10.1016/j.maturitas.2012.04.014, 22633187.
3. Singletary E, Lieberman R, Atkinson N, Sneige N, Sahin A, Tolley S, Colchin M, Bevers T, Stelling C, Fornage B, et al. Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide. Cancer Epidemiol Biomarkers Prev 2000, 9:1087-1090.
4. Thomsen A, Kolesar JM. Chemoprevention of breast cancer. Am J Health Syst Pharm 2008, 65:2221-2228. 10.2146/ajhp070663, 19020189.
5. van Breemen RB, Pajkovic N. Multitargeted therapy of cancer by lycopene. Cancer Lett 2008, 269:339-351. 10.1016/j.canlet.2008.05.016, 2615641, 18585855.
6. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012, 70:257-265. 10.1111/j.1753-4887.2012.00476.x, 22537212.
7. Cui X. Reactive oxygen species: the achilles' heel of cancer cells?. Antioxid Redox Signal 2012, 16:1212-1214. 10.1089/ars.2012.4532, 3324810, 22304673.
8. Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal 2012, 16:1295-1322. 10.1089/ars.2011.4414, 3324815, 22117137.
9. Sporn MB, Liby KT. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat Clin Pract Oncol 2005, 2:518-525. 10.1038/ncponc0319, 16205771.
10. Kwak MK, Kensler TW. Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol 2009, 244:66-76. 3584341, 19732782.
11. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354:270-282. 10.1056/NEJMra050776, 16421368.
12. McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, Wolf CR, Cavin C, Hayes JD. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001, 61:3299-3307.
13. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002, 62:5196-5203.
14. van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, Yuan L, Yang Y, Bowen PE, Stacewicz-Sapuntzakis M. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prev Res (Phila) 2011, 4:711-718. 10.1158/1940-6207.CAPR-10-0288, 3088784, 21430075.
15. Qiu X, Yuan Y, Vaishnav A, Tessel MA, Nonn L, van Breemen RB. Effects of lycopene on protein expression in human primary prostatic epithelial cells. Cancer Prev Res (Phila) 2013, 6:419-427. 10.1158/1940-6207.CAPR-12-0364, 23483004.
16. Nabeyama A, Kurita A, Asano K, Miyake Y, Yasuda T, Miura I, Nishitai G, Arakawa S, Shimizu S, Wakana S, et al. xCT deficiency accelerates chemically induced tumorigenesis. Proc Natl Acad Sci U S A 2010, 107:6436-6441. 10.1073/pnas.0912827107, 2852021, 20308543.
17. Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006, 8:99-106. 10.1089/ars.2006.8.99, 16487042.
18. Du Y, Villeneuve NF, Wang XJ, Sun Z, Chen W, Li J, Lou H, Wong PK, Zhang DD. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ Health Perspect 2008, 116:1154-1161. 10.1289/ehp.11464, 2535615, 18795156.
19. Wang ZJ, Wo SK, Wang L, Lau CB, Lee VH, Chow MS, Zuo Z. Simultaneous quantification of active components in the herbs and products of Si-Wu-Tang by high performance liquid chromatography-mass spectrometry. J Pharm Biomed Anal 2009, 50:232-244. 10.1016/j.jpba.2009.04.001, 19423264.
20. Yeh LL, Liu JY, Lin KS, Liu YS, Chiou JM, Liang KY, Tsai TF, Wang LH, Chen CT, Huang CY. A randomised placebo-controlled trial of a traditional Chinese herbal formula in the treatment of primary dysmenorrhoea. PLoS One 2007, 2:e719. 10.1371/journal.pone.0000719, 1940310, 17710126.
21. Ohta H, Ni JW, Matsumoto K, Watanabe H, Shimizu M. Peony and its major constituent, paeoniflorin, improve radial maze performance impaired by scopolamine in rats. Pharmacol Biochem Behav 1993, 45:719-723. 10.1016/0091-3057(93)90530-7, 8332629.
22. Watanabe H. Protective effect of a traditional medicine, shimotsu-to, on brain lesion in rats. J Toxicol Sci 1998, 23(Suppl 2):234-236.
23. Zhang H, Shen P, Cheng Y. Identification and determination of the major constituents in traditional Chinese medicine Si-Wu-Tang by HPLC coupled with DAD and ESI-MS. J Pharm Biomed Anal 2004, 34:705-713. 10.1016/S0731-7085(03)00650-2, 15127827.
24. Tagami K, Niwa K, Lian Z, Gao J, Mori H, Tamaya T. Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol Pharm Bull 2004, 27:156-161. 10.1248/bpb.27.156, 14758024.
25. Hsu HY, Ho YH, Lin CC. Protection of mouse bone marrow by Si-WU-Tang against whole body irradiation. J Ethnopharmacol 1996, 52:113-117. 10.1016/0378-8741(96)01400-6, 8735456.
26. Liang QD, Gao Y, Tan HL, Guo P, Li YF, Zhou Z, Tan W, Ma ZC, Ma BP, Wang SQ. Effects of four Si-Wu-Tang's constituents and their combination on irradiated mice. Biol Pharm Bull 2006, 29:1378-1382. 10.1248/bpb.29.1378, 16819172.
27. Niwa K, Hashimoto M, Morishita S, Lian Z, Tagami K, Mori H, Tamaya T. Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice. Carcinogenesis 2001, 22:587-591. 10.1093/carcin/22.4.587, 11285193.
28. Lian Z, Niwa K, Onogi K, Mori H, Harrigan RC, Tamaya T. Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. Oncol Rep 2006, 15:1133-1136.
29. Wu CJ, Chen JT, Yen TL, Jayakumar T, Chou DS, Hsiao G, Sheu JR. Neuroprotection by the Traditional Chinese Medicine, Tao-Hong-Si-Wu-Tang, against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia in Rats. Evid Based Complement Alternat Med 2011, 2011:803015. 2975073, 21076527.
30. Wen Z, Wang Z, Wang S, Ravula R, Yang L, Xu J, Wang C, Zuo Z, Chow MS, Shi L, Huang Y. Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map. PLoS One 2011, 6:e18278. 10.1371/journal.pone.0018278, 3065471, 21464939.
31. Jeong WS, Keum YS, Chen C, Jain MR, Shen G, Kim JH, Li W, Kong AN. Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J Biochem Mol Biol 2005, 38:167-176. 10.5483/BMBRep.2005.38.2.167, 15826493.
32. Cerella C, DAlessio M, Cristofanon S, De Nicola M, Radogna F, Dicato M, Diederich M, Ghibelli L. Subapoptogenic oxidative stress strongly increases the activity of the glycolytic key enzyme glyceraldehyde 3-phosphate dehydrogenase. Ann N Y Acad Sci 2009, 1171:583-590. 10.1111/j.1749-6632.2009.04723.x, 19723108.
33. Woo JM, Shin DY, Lee SJ, Joe Y, Zheng M, Yim JH, Callaway Z, Chung HT. Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen. Molecular vision 2012, 18:901-908. 3335783, 22539869.
34. Raschke M, Rowland IR, Magee PJ, Pool-Zobel BL. Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress. Carcinogenesis 2006, 27:2322-2330. 10.1093/carcin/bgl082, 16774941.
35. Kuang X, Yao Y, Du JR, Liu YX, Wang CY, Qian ZM. Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Res 2006, 1102:145-153. 10.1016/j.brainres.2006.04.110, 16806112.
36. Dietz BM, Liu D, Hagos GK, Yao P, Schinkovitz A, Pro SM, Deng S, Farnsworth NR, Pauli GF, van Breemen RB, Bolton JL. Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1. Chem Res Toxicol 2008, 21:1939-1948. 10.1021/tx8001274, 2615640, 18808158.
37. Rong S, Zhao Y, Bao W, Xiao X, Wang D, Nussler AK, Yan H, Yao P, Liu L. Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity. Phytomedicine 2012, 19:545-550. 10.1016/j.phymed.2011.12.006, 22445643.
38. Khaw AK, Hande MP, Kalthur G. Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells. J Cell Biochem 2013, 114:1257-1270. 10.1002/jcb.24466, 23192708.
39. Zhou JR, Yu L, Zhong Y, Blackburn GL. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 2003, 133:516-521. 2683253, 12566493.
40. The state pharmacopoeia commission of P.R. China Pharmacopoeia of the Peoples REpublic of China 2005, Beijing: Chemical Industry Press, The state pharmacopoeia commission of P.R. China.
41. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, Leitinger N. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 2003, 278:51006-51014. 10.1074/jbc.M304103200, 14523007.
42. Cornblatt BS, Ye L, Dinkova-Kostova AT, Erb M, Fahey JW, Singh NK, Chen MS, Stierer T, Garrett-Mayer E, Argani P, et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 2007, 28:1485-1490. 10.1093/carcin/bgm049, 17347138.